行情

FWP

FWP

Forward Pharma
NASDAQ

实时行情|Nasdaq Last Sale

6.83
-0.15
-2.08%
交易中 10:30 01/24 EST
开盘
6.81
昨收
6.97
最高
6.88
最低
6.81
成交量
1,790
成交额
--
52周最高
11.48
52周最低
5.26
市值
2,300.23万
市盈率(TTM)
-0.1497
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

FWP 新闻

  • 美国财长:希望年内能完成与英国的贸易谈判
  • 新浪财经综合.3小时前
  • 黑田东彦:日本央行将继续实施宽松政策一段时间
  • 新浪财经.3小时前
  • 美国财长:GDP增速比预期低 因波音与通用遭遇困难
  • 新浪财经综合.3小时前
  • 搜狐与畅游达成收购协议 后者的股权价值约5.79亿美元
  • 新浪财经.4小时前

更多

所属板块

生物技术和医学研究
-1.04%
制药与医学研究
-0.93%

热门股票

名称
价格
涨跌幅

FWP 简况

Forward Pharma A/S is a clinical-stage biopharmaceutical company. The Company is engaged in the development of FP187, a formulation of dimethyl fumarate (DMF) for the treatment of several inflammatory and neurological indications, including multiple sclerosis (MS). The Company's clinical candidate, FP187, is under development for the treatment of relapsing remitting MS (RRMS) and other immune disorders, such as psoriasis. The Company's DMF formulation, FP187, employs over two methods, which improves the release of DMF by reducing the peaks of monomethyl fumarate (MMF) in the bloodstream while maintaining overall DMF exposure levels, which, in turn, controls DMF's side effects. The Company has conducted a pre-clinical program and has completed several Phase I and Phase II clinical trials for the product FP187.
展开

Webull提供Forward Pharma A/S的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。